330 related articles for article (PubMed ID: 24002030)
1. Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry.
Hsu JC; Varosy PD; Bao H; Dewland TA; Curtis JP; Marcus GM
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):582-90. PubMed ID: 24002030
[TBL] [Abstract][Full Text] [Related]
2. Procedure timing as a predictor of inhospital adverse outcomes from implantable cardioverter-defibrillator implantation: insights from the National Cardiovascular Data Registry.
Hsu JC; Varosy PD; Parzynski CS; Chaudhry SI; Dewland TA; Curtis JP; Marcus GM
Am Heart J; 2015 Jan; 169(1):45-52.e3. PubMed ID: 25497247
[TBL] [Abstract][Full Text] [Related]
3. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database.
Krahn AD; Lee DS; Birnie D; Healey JS; Crystal E; Dorian P; Simpson CS; Khaykin Y; Cameron D; Janmohamed A; Yee R; Austin PC; Chen Z; Hardy J; Tu JV;
Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):136-42. PubMed ID: 21325209
[TBL] [Abstract][Full Text] [Related]
4. Predictors of an inadequate defibrillation safety margin at ICD implantation: insights from the National Cardiovascular Data Registry.
Hsu JC; Marcus GM; Al-Khatib SM; Wang Y; Curtis JP; Sood N; Parker MW; Kluger J; Lampert R; Russo AM
J Am Coll Cardiol; 2014 Jul; 64(3):256-64. PubMed ID: 25034061
[TBL] [Abstract][Full Text] [Related]
5. Coronary Venous Dissection from Left Ventricular Lead Placement During Cardiac Resynchronization Therapy With Defibrillator Implantation and Associated in-Hospital Adverse Events (from the NCDR ICD Registry).
Hsu JC; Varosy PD; Bao H; Dewland TA; Curtis JP; Marcus GM
Am J Cardiol; 2018 Jan; 121(1):55-61. PubMed ID: 29102348
[TBL] [Abstract][Full Text] [Related]
6. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry.
Dewland TA; Pellegrini CN; Wang Y; Marcus GM; Keung E; Varosy PD
J Am Coll Cardiol; 2011 Aug; 58(10):1007-13. PubMed ID: 21867834
[TBL] [Abstract][Full Text] [Related]
7. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA
Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884
[TBL] [Abstract][Full Text] [Related]
8. Incidence and predictors of clinically relevant cardiac perforation associated with systematic implantation of active-fixation pacing and defibrillation leads: a single-centre experience with over 3800 implanted leads.
Cano Ó; Andrés A; Alonso P; Osca J; Sancho-Tello MJ; Olagüe J; Martínez-Dolz L
Europace; 2017 Jan; 19(1):96-102. PubMed ID: 26847075
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
[TBL] [Abstract][Full Text] [Related]
10. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).
Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP
Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077
[TBL] [Abstract][Full Text] [Related]
11. Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: analysis from the LEADER registry.
Sadoul N; Defaye P; Mouton E; Bizeau O; Dupuis JM; Blangy H; Delarche N; Blanc JJ; Lazarus A;
Arch Cardiovasc Dis; 2013 Nov; 106(11):562-9. PubMed ID: 24200925
[TBL] [Abstract][Full Text] [Related]
12. In-hospital complications associated with reoperations of implantable cardioverter defibrillators.
Steckman DA; Varosy PD; Parzynski CS; Masoudi FA; Curtis JP; Sauer WH; Nguyen DT
Am J Cardiol; 2014 Aug; 114(3):419-26. PubMed ID: 24927972
[TBL] [Abstract][Full Text] [Related]
13. Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.
Tajstra M; Gadula-Gacek E; Kurek A; Adamowicz-Czoch E; Olszowski D; Ostręga M; Ciślak A; Pyka Ł; Hawranek M; Lekston A; Poloński L; Gąsior M
Cardiol J; 2017; 24(5):515-522. PubMed ID: 27734455
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and outcomes of diabetic patients with an implantable cardioverter defibrillator in a real world setting: results from the Israeli ICD registry.
Steiner H; Geist M; Goldenberg I; Suleiman M; Glikson M; Tenenbaum A; Swissa M; Fisman EZ; Golovchiner G; Strasberg B; Barsheshet A;
Cardiovasc Diabetol; 2016 Dec; 15(1):160. PubMed ID: 27905927
[TBL] [Abstract][Full Text] [Related]
15. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
[TBL] [Abstract][Full Text] [Related]
16. Risk of hematoma complications after device implant in the clopidogrel era.
Kutinsky IB; Jarandilla R; Jewett M; Haines DE
Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):312-8. PubMed ID: 20558847
[TBL] [Abstract][Full Text] [Related]
17. Low body mass index but not obesity is associated with in-hospital adverse events and mortality among implantable cardioverter-defibrillator recipients: insights from the National Cardiovascular Data Registry.
Hsu JC; Varosy PD; Bao H; Wang Y; Curtis JP; Marcus GM
J Am Heart Assoc; 2012 Dec; 1(6):e003863. PubMed ID: 23316325
[TBL] [Abstract][Full Text] [Related]
18. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
19. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit.
Parkash R; Sapp JL; Basta M; Doucette S; Thompson K; Gardner M; Gray C; Brownell B; Kidwai H; Cox J
Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):706-13. PubMed ID: 22685111
[TBL] [Abstract][Full Text] [Related]
20. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
